Skip to content

Auph stock price target

HomeWieciech47116Auph stock price target
16.12.2020

AUPH Aurinia Pharmaceuticals Inc. — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss … Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stock Plunged ... Mar 09, 2020 · The AUPH stock was last observed hovering at around $18.81 in the last trading session, with the day’s loss setting it -1.95% off its average median price target of $24.00 for the next 12 months. It is also 47.31% off the consensus price target high of $32.00 offered by 8 analysts, but current levels are 15.7% higher than the price target low Aurinia Pharmaceuticals Inc (AUPH) Latest Stock News ...

Mar 07, 2020 · On Thursday, shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) marked $18.81 per share versus a previous $18.52 closing price. With having a 1.57% gain, an insight into the fundamental values of Aurinia Pharmaceuticals Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote ... Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. Aurinia Pharmaceuticals Inc. - NASDAQ:AUPH - Stock Quote ... View detailed financial information, real-time news, videos, quotes and analysis on Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). Explore commentary on …

Are Aurinia Pharmaceuticals Inc. (AUPH) Shares Headed For ...

AUPH - Aurinia Pharm Ord Stock Price - Barchart.com It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided …

Aurinia Pharmaceuticals Inc (AUPH) Gets a Price Target ...

Jul 15, 2019 · AUPH – This a truly unique list of stocks. That’s because each has at least 100% upside potential to the average target price set by Wall Street Analysts. Earnings Announcements - Zacks Investment Research: Stock ... AUPH: Aurinia Pharmaceuticals Inc - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Aurinia Pharmaceuticals Inc from Zacks Investment Research Aurinia Pharmaceuticals Inc (AUPH) stock price, quote ... Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, announced today that the Company has initiated a Rolling Submission of its New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") for

Looks like AUPH is in the start of an uptrend after the $6 support level that developed. I am looking enter in at $6.60 with a stop limit set at $6.38, just below the old support at $6.40 back on April 6, 2017. Also, the price is closer to the bottom of the sideways trend so hoping for a move up back to the $7.90 price level.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stock Plunged ... Mar 09, 2020 · The AUPH stock was last observed hovering at around $18.81 in the last trading session, with the day’s loss setting it -1.95% off its average median price target of $24.00 for the next 12 months. It is also 47.31% off the consensus price target high of $32.00 offered by 8 analysts, but current levels are 15.7% higher than the price target low Aurinia Pharmaceuticals Inc (AUPH) Latest Stock News ... Get the latest Aurinia Pharmaceuticals Inc (AUPH) stock news and headlines to help you in your trading and investing decisions. Buy rating and set a price target of $27. attention to Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Average ... NASDAQ AUPH opened at $20.69 on Tuesday. The stock’s 50-day moving average price is $15.05 and its two-hundred day moving average price is $8.05. The company has a market cap of $2.21 billion, a PE ratio of -27.22 and a beta of 1.68. Aurinia Pharmaceuticals has a 1 year low of $3.52 and a 1 year high of $21.93.